1. Home
  2. AFMD vs LSB Comparison

AFMD vs LSB Comparison

Compare AFMD & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • LSB
  • Stock Information
  • Founded
  • AFMD 2000
  • LSB 2002
  • Country
  • AFMD Germany
  • LSB China
  • Employees
  • AFMD N/A
  • LSB N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • LSB
  • Sector
  • AFMD Health Care
  • LSB
  • Exchange
  • AFMD Nasdaq
  • LSB NYSE
  • Market Cap
  • AFMD 45.6M
  • LSB 49.8M
  • IPO Year
  • AFMD 2014
  • LSB N/A
  • Fundamental
  • Price
  • AFMD $1.27
  • LSB $2.51
  • Analyst Decision
  • AFMD Strong Buy
  • LSB
  • Analyst Count
  • AFMD 5
  • LSB 0
  • Target Price
  • AFMD $13.50
  • LSB N/A
  • AVG Volume (30 Days)
  • AFMD 498.2K
  • LSB 15.7K
  • Earning Date
  • AFMD 11-14-2024
  • LSB 01-21-2025
  • Dividend Yield
  • AFMD N/A
  • LSB N/A
  • EPS Growth
  • AFMD N/A
  • LSB N/A
  • EPS
  • AFMD N/A
  • LSB N/A
  • Revenue
  • AFMD $6,287,085.00
  • LSB $79,415,311.00
  • Revenue This Year
  • AFMD N/A
  • LSB $39.33
  • Revenue Next Year
  • AFMD $28.44
  • LSB $75.61
  • P/E Ratio
  • AFMD N/A
  • LSB N/A
  • Revenue Growth
  • AFMD N/A
  • LSB N/A
  • 52 Week Low
  • AFMD $1.40
  • LSB $1.88
  • 52 Week High
  • AFMD $8.95
  • LSB $11.20
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 16.00
  • LSB 44.96
  • Support Level
  • AFMD $1.40
  • LSB $2.10
  • Resistance Level
  • AFMD $2.21
  • LSB $2.77
  • Average True Range (ATR)
  • AFMD 0.24
  • LSB 0.36
  • MACD
  • AFMD -0.08
  • LSB 0.01
  • Stochastic Oscillator
  • AFMD 3.33
  • LSB 34.68

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About LSB LAKESHORE BIOPHARMA CO LTD

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: